Clinical analysis revealed subtype-specific prognostic value, where high EIF4EBP1 expression correlated with poor survival in lung adenocarcinoma (LUAD) but favorable outcomes in squamous cell carcinoma (LUSC). Here, EIF4EBP1 is linked to squamous cell carcinoma.